ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IMUX Immunic Inc

1.33
0.00 (0.00%)
Pre Market
Last Updated: 04:24:40
Delayed by 15 minutes

Period:

Draw Mode:

Volume 69
Bid Price 1.31
Ask Price 1.32
News -
Day High

Low
0.9451

52 Week Range

High
3.11

Day Low
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.33 04:24:40
Open Price Low Price High Price Close Price Prev Close
1.33
Trades Volume Avg Volume 52 Week Range
2 69 - 0.9451 - 3.11
Last Trade Time Type Quantity Stock Price Currency
04:00:00 50 $ 1.31 USD

Immunic Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
119.61M 89.93M - 0 -93.61M -1.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Immunic News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IMUX Message Board. Create One! See More Posts on IMUX Message Board See More Message Board Posts

Historical IMUX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.461.461.261.32884,009-0.13-8.90%
1 Month1.301.641.171.37808,7810.032.31%
3 Months1.441.731.091.321,077,837-0.11-7.64%
6 Months1.381.920.94511.31909,297-0.05-3.62%
1 Year1.663.110.94511.62854,143-0.33-19.88%
3 Years15.0016.990.94514.41838,178-13.67-91.13%
5 Years22.0028.21380.94516.09594,841-20.67-93.95%

Immunic Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.

Your Recent History

Delayed Upgrade Clock